Nanoencapsulation of water-soluble drug, lamivudine, using a double emulsion spray-drying technique for improving HIV treatment

Journal of Nanoparticle Research

Volumn 15, Issue 11, 2013, Pages

  Tshweu, Lesego ^a   Katata, Lebogang ^b   Kalombo, Lonji ^a   Swai, Hulda ^a  

^a DSI CSIR Nanotechnology Innovation Centre   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Double emulsion; Lamivudine; Nanomedicine; Nanoparticles; Poly(epsiloncaprolactone); Spray dried

Indexed keywords

DICHLOROMETHANE; DISEASES; DRUG PRODUCTS; EMULSIFICATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; POLYDISPERSITY; SPRAY DRYING; SUGARS; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; ULTRAVIOLET SPECTROSCOPY; VIRUSES;

BIODEGRADABLE NANOPARTICLE; DOUBLE EMULSIONS; ENCAPSULATION EFFICIENCY; HUMAN IMMUNODEFICIENCY VIRUS; LAMIVUDINE; POLY (EPSILONCAPROLACTONE); SPHERICAL NANOPARTICLES; SPRAY DRIED;

CONTROLLED DRUG DELIVERY;

EXCIPIENT; LAMIVUDINE; NANOPARTICLE; POLYCAPROLACTONE;

ARTICLE; DOUBLE EMULSION SPRAY DRYING TECHNIQUE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NANOENCAPSULATION; PARTICLE SIZE; PLASMA HALF LIFE; PRIORITY JOURNAL; PROCEDURES; SYNTHESIS; ZETA POTENTIAL;

EID: 84885487594     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-2040-4     Document Type: Article

References (39)

1. Arpagaus C, Meuri M (2010) Laboratory scale spray drying of inhalable particles: a review, Respir Drug Deliv VCU: 469-473
2. Baras B, Benoit MA, Gillard J (2000) Influence of various technological parameters on the preparation of spray-dried poly (ε-caprolactone) microparticles containing a model antigen. J Microencapsul 17(4):485-498
3. Broadhead J, Rouan SKE, Rhodes CT (1992) The spray drying of pharmaceuticals. Drug Dev Ind Pharm 18:1169-1206
4. Caroline MP, Faulds D (1997) Lamivudine: a review of its antiretroviral activity. Pharmacokinetic property and therapeutic efficiency in management of HIV infection. Drugs 53:7-680
5. Chernysheva YV, Babak VG, Kildeeva NR, Boury, Benoil F (2003) Effect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification-solvent evaporation. Mendeleev Commun 13(2):65-67
6. Clercq ED (2009) Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents 33:307-320
7. das Neves J, Amiji MM, Bahia MF, Sarmento B (2010) Nano-technology-based systems for the treatment and prevention of HIV/AIDS. Adv Drug Deliv Rev 62:458-477
8. Dash TK, Konkimalla VB (2012) Poly-ε-caprolactone based formulations for drug delivery and tissue engineering: a review. J Control Rel 158:15-33
9. Dash S, Ng WK, Kanaujia P, Kim S, Tan RBH (2012) Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B: Biointerf 88:483-489
10. Dev A, Binulal NS, Anitha A, Nair SV, Furuike T, Tamura H, Jayakumar R (2010) Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug. Carbohydr Polym 80:833-838
11. Gupta U, Jain NK (2010) Non-polymeric nano-carriers in HIV/AIDS drug deliveryand targeting. Adv Drug Deliv Rev 62:478-490
12. Higashiyama T (2002) Novel fuctions and applications of trehalose. Pure Appl Chem 74(7):1263-1269
13. Inez MV, Kersten G, Marjan MF, Beuvery C, Verhoef JC, Junginger HE (2003) Chitosan microparticles for mucosal vaccination against diphtheria:oral and nasal efficacy studies in mice. Vaccine 21:13-14
14. Jozwiakowski MJ, Nguyen NT, SiscoI JM, Spancake CW (1996) Solubility behaviour of Lamivudine crystal forms in recrystallization solvents. J Pharm Sci 85:193-199
15. Jyothi NVN, Prasanna PM, Sakarkar SN, Prabha KS, Ramaiah PS, Srawan, Srawan GY (2010) Microencapsulation techniques, factors influencing encapsulation efficiency. J Microencapsul 27(3):187-197
16. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS (2000) Hepatitis B genotype and response to interferon therapy. J Hepatol 33:998-1002
17. Katata L, Tshweu L, Naidoo S, Kalombo L, Swai H (2012) Design and formulation of nano-sized spray dried Efavirenz-Part I: influence of formulation parameters. J Nanopart Res 14:1247
18. Kho K, Cheow WS, Lie RH, Hadinoto K (2010) Aqueous redispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticles aggregate for inhaled anti-biofilm therapy. Powder Technol 203:432-439
19. Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B 75:1-18
20. Look M, Bandyopadhyay A, Blum JS, Fahmy JM (2010) Application of nanotechnologies for improved immune response against infectious diseases in the developing world. Adv Drug Deliv Rev 62:378-393
21. Luong-Van E, Grondahl L, Nurcombe V, Cool S (2007) In vitro biocompatibility and bioactivity of microencapsulated heparan sulfate. Biomaterials 28:2127-2136
22. Maia J, Santana M (2004) The effect of some processing conditions on the characteristics of biodegradable microspheres obtained by an emulsion solvent evaporation process. Braz J Chem Eng 21:1-12
23. Mishra B, Patel BB, Tiwari S (2010) Colloidal nanocarriers: a review on formulation technology, types and application torward targeted drug delivery. Nanomed: Nanotechnol Biol Med 6:9-24
24. Mourya V, Inamdar N (2008) Chitosan-modifications and applications: opportunities galore. J React Funct Polymers 68:1013-1051
25. Proikalis CS, Tarantalli PA, Andreopoulos AG (2006) The role of polymer/drug interactions on the sustained release from poly (DL -lactic acid) tablets. Eur Polymer J 42:3269-3276
26. Rao KS, Ghorpade A, Labhasetwar V (2009) Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv 6(8):771-784
27. Rathbun, R C & Greenfield, R A (2011) Antiretroviral Therapy for HIV Infection. Available: http://emedicine.medscape.com/article/1533218-overview [Accessed 08/11/2011]
28. Roser B (1991) Trehalose drying-A novel replacement for freeze-drying. Biopharm 4:47-52
29. Sahoo S, Sasmal A, Nanda R, Phani AR, Nayak PL (2010) Synthesis of chitosan-polycaprolactone blend for control delivery of ofloxacin drug. Carbohydr Polym 79:106-113
30. Semete B, Booysen L, Lemmer Y, Kalombo L, Katata L, Verschoor J, Swai H (2010) In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine: nanotechnology. Biol Med 6:662-671
31. Shin IG, Kim SY, Lee YM, Cho CS, Sung YK (1998) Methoxypoly (ethylene glycol)/E-caprolactone amphiphilic block copolymeric micellecontaining indomethacin: I. Preparation and characterization. J Control Release 51:1-11
32. Simperler A, Kornherr A, Chopra R, Bonnet PA, Jones W, Motherwell WDS, Zifferer G (2006) Glass transition temperature of glucose, sucrose, and trehalose: an experimental and in silico study. J Phys Chem B 110:19678-19684
33. Song KC, Lee HS, Choung IY, Cho KI, Ahn Y, Choi EJ (2006) The effect of type of organic phase solvents on the particle size of poly(D, L-lactide-co-glycolide) nanoparticles. Colloids Surf A: Physicochem Eng Aspects 276:162-167
34. Takeuchi H, Yasuji T, Hino T, Yamamoto H, Kawashima Y (1998) Spray-dried composite particles of lactose and sodium alginate for direct tableting and controlled releasing. Int J Pharm 174:91-100
35. Wong HL, Chattopadhyay N, Wu XY, Bendayan R (2010) Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. Adv Drug Deliv Rev 62:503-517
36. Woodruff MA, Hutmacher DW (2010) The return of a forgotten polymer-Polycaprolactone in the 21st century. Prog Polym Sci 35:1217-1256
37. Wu CS (2005) A comparison of the structure, thermal properties, and biodegradability of polycaprolactone/chitosan and acrylic acid grafted polycaprolactone/chitosan. Polymer 46:147-155
38. Young RJ, Lovell PA (1991) Introduction to polymers, 2nd edn. CRC Press, BocaRaton, New York, Washington, DC, pp 265-266
39. Zhao Y, Fu J, Dennis KPN, Wu C (2004) Formation and degradation of poly(D, L-lactide) nanoparticles and their potential application as controllable releasing devices. Macromol Biosci 4:901-906